YTHDC1-m6A-GADD45B axis promotes hPDLSC chondrogenesis by suppressing senescence via p53/p21 pathway
Background
Temporomandibular joint osteoarthritis (TMJOA) is a debilitating degenerative disease with limited effective treatments. Stem cell-based therapies, particularly using human periodontal ligament stem cells (hPDLSCs), show promise for cartilage regeneration. However, the inflammatory and hypoxic microenvironment of TMJOA significantly accelerates hPDLSC senescence, severely compromising their regenerative capacity. Understanding and counteracting this senescence is crucial for unlocking the full therapeutic potential of hPDLSCs in TMJOA cartilage repair.
Study Design
Researchers investigated the role of the YTHDC1-m⁶A-GADD45B axis in hPDLSC senescence and chondrogenic differentiation. They cultured hPDLSCs under inflammatory and hypoxic conditions to induce senescence. Functional studies involved YTHDC1 overexpression and knockdown in hPDLSCs to assess impacts on senescence and chondrogenesis. Mechanistic investigations focused on m⁶A modifications on GADD45B mRNA and its interaction with p53/p21 signaling. Finally, YTHDC1-overexpressing hPDLSCs were transplanted into rats with TMJOA to evaluate therapeutic effects, with a control arm co-expressing wild-type GADD45B.
Results
The study identified the YTHDC1-m⁶A-GADD45B axis as a critical regulator of senescence and chondrogenic differentiation in hPDLSCs. They observed that YTHDC1, an m⁶A reader protein, was downregulated under inflammatory and senescent conditions. Functional experiments revealed that YTHDC1 overexpression attenuated senescence and enhanced chondrogenesis, while its knockdown exacerbated senescence and suppressed differentiation. Mechanistically, YTHDC1 was found to recognize m⁶A modifications on GADD45B mRNA, promoting its decay and subsequently inhibiting the p53/p21 signaling pathway. Mutation of the m⁶A site in GADD45B abolished the regulatory effects of YTHDC1. In vivo, transplantation of YTHDC1-overexpressing hPDLSCs in rats with TMJOA ameliorated disease phenotypes. This beneficial effect was reversed by co-expression of wild-type GADD45B.
Key Findings
- YTHDC1, an m⁶A reader protein, is downregulated in hPDLSCs under inflammatory and senescent conditions.
- YTHDC1 overexpression significantly attenuates hPDLSC senescence and enhances chondrogenic differentiation.
- YTHDC1 promotes
GADD45BmRNA decay viam⁶Arecognition, thereby inhibiting thep53/p21signaling pathway. - Transplantation of YTHDC1-overexpressing hPDLSCs ameliorated TMJOA phenotypes in rats.
- The therapeutic effect of YTHDC1-overexpressing hPDLSCs was reversed by co-expression of wild-type
GADD45B.
Why It Matters
This research uncovers a novel epitranscriptomic mechanism governing hPDLSC senescence and chondrogenic differentiation, offering a new therapeutic target for TMJOA. Targeting the YTHDC1-GADD45B-p53/p21 axis could enhance the regenerative potential of stem cell therapies for cartilage repair. For biohackers and clinicians, this suggests future strategies might involve modulating YTHDC1 activity or GADD45B expression to improve stem cell viability and efficacy in degenerative joint conditions. While still preclinical, this work provides a foundational understanding that could lead to optimized stem cell protocols or novel small molecule interventions to prevent senescence and promote cartilage regeneration.
tmjoa
hpdls
chondrogenesis
senescence
ythdc1
m6a